Study for primary biliary cholangitis and autoimmune hepatitis

This study is looking at specific immune cells (T cells) in the blood of people with autoimmune hepatitis (AIH) to better understand the disease. If you have untreated AIH and meet certain criteria, you may be able to participate.

This trial tests approaches to improve health outcomes for people with autoimmune liver diseases. It includes specific autoimmune conditions affecting the liver and bile ducts, and it may help your care team learn what works best for these illnesses.

This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.

This study examines the molecular profile of autoimmune hepatitis (a liver condition where the immune system attacks liver cells) using lipid analysis. Researchers hope to better understand the disease and potentially improve diagnosis and treatment in the future.

This study observes people with primary biliary cholangitis (PBC) to learn more about the disease and what factors might make it worse over time. It uses your medical history and liver biopsy results to understand how PBC progresses.

This study collects information from people with autoimmune or cholestatic liver diseases to better understand them and improve care. It does not test a new treatment, but your participation can help future research.